Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

NCT01954992 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: Glufosfamide
DRUG: Fluorouracil

Sponsor

Eleison Pharmaceuticals LLC.